Lista de obras - Marcus W Koch - Dominio Público Uruguay

A fatal demyelinating illness in a young woman 10 weeks post partum.

artículo científico publicado en 2005

Aging-Exacerbated Acute Axon and Myelin Injury Is Associated with Microglia-Derived Reactive Oxygen Species and Is Alleviated by the Generic Medication Indapamide

artículo científico publicado en 2020

An enrichment strategy for clinical trials in SPMS

scientific article published on 06 January 2021

An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination

artículo científico publicado en 2016

Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS.

artículo científico publicado en 2010

Cerebral white matter blood flow and energy metabolism in multiple sclerosis

artículo científico publicado en 2013

Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis

scientific article published on 01 July 2007

Cigarette smoking and progression in multiple sclerosis

scientific article published on 01 October 2007

Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data sets

artículo científico publicado en 2019

Comparative utility of disability progression measures in PPMS: Analysis of the PROMiSe data set.

artículo científico publicado en 2017

Depression in multiple sclerosis: a long-term longitudinal study

artículo científico publicado en 2014

Disease onset in familial and sporadic primary progressive multiple sclerosis

artículo científico publicado en 2010

Does smoking influence outcome after intravenous thrombolysis for acute ischaemic stroke?

artículo científico publicado en 2009

Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders.

artículo científico publicado en 2007

Environmental factors and their regulation of immunity in multiple sclerosis

artículo científico publicado en 2013

Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis.

artículo científico publicado en 2012

Erythrocyte membrane fatty acids in benign and progressive forms of multiple sclerosis

scientific article published on 06 March 2006

Factors associated with the risk of secondary progression in multiple sclerosis

scientific article published on 23 June 2008

Fatigue, depression and disability accumulation in multiple sclerosis: a cross-sectional study.

artículo científico publicado en 2009

Fatigue, depression and progression in multiple sclerosis

scientific article published on 05 June 2008

Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent

artículo científico publicado en 2020

Global transcriptome profiling of mild relapsing remitting versus primary progressive Multiple Sclerosis

artículo científico publicado en 2018

Hand dexterity and direct disease related cost in multiple sclerosis.

artículo científico publicado en 2014

Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis.

artículo científico publicado en 2015

Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance.

artículo científico publicado en 2008

Incidence and prevalence of multiple sclerosis in Europe: a systematic review

artículo científico publicado en 2013

Incidence and prevalence of multiple sclerosis in the Americas: a systematic review

artículo científico publicado en 2013

Interferon-β treatment and the natural history of relapsing-remitting multiple sclerosis

scientific article published on 01 January 2008

Irreversible neurological worsening following high-dose corticosteroids in advanced progressive multiple sclerosis

scientific article published on 01 January 2006

Jerking & confused: Leucine-rich glioma inactivated 1 receptor encephalitis

artículo científico publicado en 2015

Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke.

artículo científico publicado en 2008

Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study

artículo científico publicado en 2015

MS incidence and prevalence in Africa, Asia, Australia and New Zealand: A systematic review

artículo científico

Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures

artículo científico publicado en 2007

Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis

scientific article published on 14 November 2005

Parity and secondary progression in multiple sclerosis.

artículo científico publicado en 2009

Performance on Paced Auditory Serial Addition Test and cerebral blood flow in multiple sclerosis.

artículo científico publicado en 2013

Peripheral blood leukocyte NO production and oxidative stress in multiple sclerosis.

artículo científico publicado en 2007

Pharmacologic treatment of depression in multiple sclerosis

artículo científico publicado en 2008

Plasma S100beta and NSE levels and progression in multiple sclerosis

artículo científico publicado en 2006

Plasma homocysteine levels in multiple sclerosis.

artículo científico publicado en 2006

Plasma lipid peroxidation and progression of disability in multiple sclerosis.

artículo científico publicado en 2007

Primary and secondary progressive MS have a similar age at onset of progression - Commentary.

artículo científico publicado en 2017

Progression in familial and nonfamilial MS.

artículo científico publicado en 2008

Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair

artículo científico publicado en 2013

Reduced creatine kinase B activity in multiple sclerosis normal appearing white matter

artículo científico publicado en 2010

Relationship between the extent of T2 lesions and the onset of secondary progression in multiple sclerosis

artículo científico publicado en 2007

Reliability of outcome measures in clinical trials in secondary progressive multiple sclerosis

artículo científico publicado en 2020

Reproducibility over a 1-month period of 1H-MR spectroscopic imaging NAA/Cr ratios in clinically stable multiple sclerosis patients

artículo científico publicado en 2008

Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.

artículo científico publicado en 2008

Serum NSE level and disability progression in multiple sclerosis.

artículo científico publicado en 2015

Smoking does not influence disability accumulation in primary progressive multiple sclerosis.

artículo científico publicado en 2017

Subacute sclerosing panencephalitis in pregnancy

artículo científico publicado en 2016

Surgical resection in metastatic spinal cord compression

scientific article published on 01 January 2006

The natural history of early versus late disability accumulation in primary progressive MS.

artículo científico publicado en 2014

The natural history of primary progressive multiple sclerosis.

artículo científico publicado en 2009

The natural history of secondary progressive multiple sclerosis

artículo científico publicado en 2010

The promise of futility trials in neurological diseases.

artículo científico

Therapeutic potential of fluoxetine in neurological disorders

artículo científico publicado en 2008

Timing of birth and disease progression in multiple sclerosis

artículo científico publicado en 2008

Treatment of seizures in multiple sclerosis

artículo científico publicado en 2009

Treatment of seizures in multiple sclerosis

artículo científico publicado en 2008

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.

artículo científico publicado en 2007

Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?

artículo científico publicado en 2017

Uric acid in multiple sclerosis.

artículo científico publicado en 2006

Validity of four screening scales for major depression in MS.

artículo científico publicado en 2015

Lista de obras de Marcus W Koch

A fatal demyelinating illness in a young woman 10 weeks post partum.

Aging-Exacerbated Acute Axon and Myelin Injury Is Associated with Microglia-Derived Reactive Oxygen Species and Is Alleviated by the Generic Medication Indapamide

An enrichment strategy for clinical trials in SPMS

An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination

Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS.

Cerebral white matter blood flow and energy metabolism in multiple sclerosis

Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis

Cigarette smoking and progression in multiple sclerosis

Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data sets

Comparative utility of disability progression measures in PPMS: Analysis of the PROMiSe data set.

Depression in multiple sclerosis: a long-term longitudinal study

Disease onset in familial and sporadic primary progressive multiple sclerosis

Does smoking influence outcome after intravenous thrombolysis for acute ischaemic stroke?

Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders.

Environmental factors and their regulation of immunity in multiple sclerosis

Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis.

Erythrocyte membrane fatty acids in benign and progressive forms of multiple sclerosis

Factors associated with the risk of secondary progression in multiple sclerosis

Fatigue, depression and disability accumulation in multiple sclerosis: a cross-sectional study.

Fatigue, depression and progression in multiple sclerosis

Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent

Global transcriptome profiling of mild relapsing remitting versus primary progressive Multiple Sclerosis

Hand dexterity and direct disease related cost in multiple sclerosis.

Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis.

Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance.

Incidence and prevalence of multiple sclerosis in Europe: a systematic review

Incidence and prevalence of multiple sclerosis in the Americas: a systematic review

Interferon-β treatment and the natural history of relapsing-remitting multiple sclerosis

Irreversible neurological worsening following high-dose corticosteroids in advanced progressive multiple sclerosis

Jerking & confused: Leucine-rich glioma inactivated 1 receptor encephalitis

Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke.

Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study

MS incidence and prevalence in Africa, Asia, Australia and New Zealand: A systematic review

Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures

Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis

Parity and secondary progression in multiple sclerosis.

Performance on Paced Auditory Serial Addition Test and cerebral blood flow in multiple sclerosis.

Peripheral blood leukocyte NO production and oxidative stress in multiple sclerosis.

Pharmacologic treatment of depression in multiple sclerosis

Plasma S100beta and NSE levels and progression in multiple sclerosis

Plasma homocysteine levels in multiple sclerosis.

Plasma lipid peroxidation and progression of disability in multiple sclerosis.

Primary and secondary progressive MS have a similar age at onset of progression - Commentary.

Progression in familial and nonfamilial MS.

Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair

Reduced creatine kinase B activity in multiple sclerosis normal appearing white matter

Relationship between the extent of T2 lesions and the onset of secondary progression in multiple sclerosis

Reliability of outcome measures in clinical trials in secondary progressive multiple sclerosis

Reproducibility over a 1-month period of 1H-MR spectroscopic imaging NAA/Cr ratios in clinically stable multiple sclerosis patients

Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.

Serum NSE level and disability progression in multiple sclerosis.

Smoking does not influence disability accumulation in primary progressive multiple sclerosis.

Subacute sclerosing panencephalitis in pregnancy

Surgical resection in metastatic spinal cord compression

The natural history of early versus late disability accumulation in primary progressive MS.

The natural history of primary progressive multiple sclerosis.

The natural history of secondary progressive multiple sclerosis

The promise of futility trials in neurological diseases.

Therapeutic potential of fluoxetine in neurological disorders

Timing of birth and disease progression in multiple sclerosis

Treatment of seizures in multiple sclerosis

Treatment of seizures in multiple sclerosis

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.

Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?

Uric acid in multiple sclerosis.

Validity of four screening scales for major depression in MS.